Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by University of California, Davis
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01736943
First received: November 26, 2012
Last updated: January 27, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)